| Cas No.: | 242138-07-4 |
| pH value: | Corresponds to reference standard: PASS |
| Non-reduced CE-SDS: | 98.6% |
| SEC-HPLC: | 99.3% |
| Isoelectric Point: | Corresponds to reference standard:PASS |
| Bacterial Endotoxins Test: | <1 EU/ml |
| Exogenous Residual DNA: | 1 pg/mg |
| Residual protein A: | <1 ng/mg |
| Biological Activity: | Compared with standard, the range of biological activity is 103% |
| Osmolality: | Corresponds to reference standard: PASS |
| Peptide mapping: | Corresponds to reference standard: PASS |
| N-terminal sequence: | Corresponds to reference standard:PASS |
| Description: | Omalizumab is a monoclonal antibody targeting the high-affinity receptor binding site on human immunoglobulin (Ig)E to treat an asthma attack. |

To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
